As debate surrounding the use and marketing of e-cigarettes and vapes has swirled around Washington for the past few months, one of the most important voices has, buy-in-large, been entirely ignored. The moderately sized group of protesters that rallied outside of the White House on November 9th to protest President Trump’s proposed ban on e-cigarettes went all but unmentioned in the mainstream media. Their signs were simple and to-the-point: “We Vape. We Vote.” And vote they will.

This week, the House Oversight and Reform Committee’s Subcommittee on Economic and Consumer Policy will hold hearings entitled, “Examining JUUL’s Role in the Youth Nicotine Epidemic.” In the hearing, the Subcommittee is expected to discuss JUUL’s marketing practices and other strategies that may have contributed to the rise in youth vaping over the past few years.

Welcome to FreedomWorks Foundation’s seventh regulatory review of 2019! Our Regulatory Action Center proudly updates you with our favorite tidbits from the swamp. We want to smash barriers between bureaucracy and the American people by delivering regulatory news straight to FreedomWorks activists. Check back in two weeks for the next edition.

Welcome to FreedomWorks Foundation’s second regulatory review of 2019! Our Regulatory Action Center proudly updates you with our favorite tidbits from the swamp. We want to smash barriers between bureaucracy and the American people by delivering regulatory news straight to FreedomWorks activists. Check back in two weeks for the next edition.

1) Video of the Week: In this video, the Cato Institute’s Ryan Bourne and Vanessa Brown Calder joined Diane Katz of the Heritage Foundation to talk about federal regulations that disproportionately harm low income Americans.

On behalf of our activist community, I urge you to contact your representative and ask him or her to cosponsor the FDA Deeming Authority Clarification Act, H.R. 1136, introduced by Rep. Tom Cole (R-Okla.) and Rep. Sanford Bishop (D-Ga.). The bill would save e-cigarette and vaping producers from a Food and Drug Administration rule finalized by the agency in May 2016.